L K Oyewumi, Y Al-Semaan. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Agranulocytosis/bloodAgranulocytosis/chemically inducedAntipsychotic Agents/administration & dosageAntipsychotic Agents/adverse effectsBenzodiazepinesClozapine/administration & dosageClozapine/adverse effectsHumansMaleMiddle AgedOlanzapinePirenzepine/administration & dosagePirenzepine/adverse effectsPirenzepine/analogs & derivativesPsychiatric Status Rating ScalesSchizophrenia/bloodSchizophrenia/drug therapyTreatment Outcome
Substances: See more » Antipsychotic AgentsBenzodiazepinesPirenzepineClozapineOlanzapine
Year: 2000 PMID: 10770478 DOI: 10.1097/00004714-200004000-00032
Source DB: PubMed Journal: J Clin Psychopharmacol ISSN: 0271-0749 Impact factor: 3.153